Literature DB >> 3471760

Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta.

R A Ignotz, T Endo, J Massagué.   

Abstract

Human platelet-derived transforming growth factor-beta (TGF-beta 1) increases the accumulation of the extracellular matrix proteins, fibronectin and type I collagen, in mesenchymal and epithelial cells. To determine the basis for this effect, we have examined the levels of mRNAs corresponding to fibronectin and alpha 2(I) procollagen in NRK-49 rat fibroblasts and L6E9 rat myoblasts treated with TGF-beta 1. TGF-beta 1 increased severalfold the levels of mRNAs for both proteins. The kinetics of this effect were similar for both mRNA species. The increase in fibronectin and alpha 2(I) procollagen mRNAs was detectable 2 h after addition of TGF-beta 1 to the cells and their maximal levels remained constant for several days. Actinomycin D, but not cycloheximide, inhibited the increase in fibronectin and alpha 2(I) procollagen mRNA levels induced by TGF-beta 1. The results indicate that TGF-beta 1 controls the composition and abundance of extracellular matrices at least in part by inducing a coordinate increase in the levels of fibronectin and type I collagen mRNAs.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3471760

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  135 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients.

Authors:  A J Coito; K Onodera; H Kato; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 4.  Pharmacotherapy and airway remodelling in asthma?

Authors:  P A Beckett; P H Howarth
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

5.  Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells.

Authors:  J P Taylor; C Cupp; A Diaz; M Chowdhury; K Khalili; S A Jimenez; S Amini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Changes in the extracellular matrix of the normal human breast during the menstrual cycle.

Authors:  J E Ferguson; A M Schor; A Howell; M W Ferguson
Journal:  Cell Tissue Res       Date:  1992-04       Impact factor: 5.249

7.  TGF-β1 enhances contractility in engineered skeletal muscle.

Authors:  Michael R Weist; Michael S Wellington; Jacob E Bermudez; Tatiana Y Kostrominova; Christopher L Mendias; Ellen M Arruda; Lisa M Larkin
Journal:  J Tissue Eng Regen Med       Date:  2012-02-27       Impact factor: 3.963

8.  Latent TGF-β binding protein 4 promotes elastic fiber assembly by interacting with fibulin-5.

Authors:  Kazuo Noda; Branka Dabovic; Kyoko Takagi; Tadashi Inoue; Masahito Horiguchi; Maretoshi Hirai; Yusuke Fujikawa; Tomoya O Akama; Kenji Kusumoto; Lior Zilberberg; Lynn Y Sakai; Katri Koli; Motoko Naitoh; Harald von Melchner; Shigehiko Suzuki; Daniel B Rifkin; Tomoyuki Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase.

Authors:  H P Marti; L Lee; M Kashgarian; D H Lovett
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

10.  Modulation of human breast cancer cell adhesion by estrogens and antiestrogens.

Authors:  R Millon; F Nicora; D Muller; M Eber; C Klein-Soyer; J Abecassis
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.